On August 2, 2013, the Food and Drug Administration (FDA) announced its long-awaited gluten-free food labeling rule. According to the rule, when a manufacturer chooses to put “gluten-free” on food packaging, the item must comply with the new FDA definition of the term – less than 20 parts per million (ppm) of gluten. Manufacturers were […]
Celiac Disease Foundation (CDF) launched the nation’s most comprehensive online directory for patients to find reliable information on healthcare practitioners familiar with diagnosing and treating celiac disease and other gluten-related disorders. From coast to coast, patients can search by ZIP code to help them choose a healthcare practitioner in their town who will understand their […]
The FDA last month released a regulation defining the term “gluten-free” for voluntary food labeling. The regulation sets a standard of no more than 20 parts per million of gluten for a product to be labeled as gluten-free, among other requirements. The standard “is consistent with that set by other countries and international bodies that […]
For more than 20 years, Celiac Disease Foundation has been the trusted source for the dissemination of evidence-based research regarding celiac disease. CEO Marilyn G. Geller challenges the science behind a controversial new report alleging that genetically engineered foods could be an environmental trigger for celiac disease and gluten sensitivity.
FDA clarifies what the Gluten-Free Labeling Rule means for restaurants – considers enforcement action to protect consumers
CEO Marilyn Geller discusses the difficulty in obtaining a celiac disease diagnosis and what is a gluten-free diet with Cristina Ferrare and Mark Steines, hosts of the Hallmark Channel’s Home and Family Show.
The CDF funded study, The Prevalence of Celiac Disease in a Primarily Hispanic Population as seen at Olive View Medical Center, will not only evaluate the incidence of celiac disease in multiple groups of patients at Olive View – UCLA Medical Center; it also has the potential to raise awareness of the disease in the […]
Introduced: May 15, 2013 (113th U.S. Congress, 2013-2015) Status: Referred to Committee CDF Update – June 18, 2013 On the eve of International Celiac Disease Awareness Day (May 16, 2013), Representatives Tim Ryan (D-OH) and Nita Lowey (D-NY) introduced the Gluten in Medicine Disclosure Act – HR 2003 to the U.S. Congress. The Act will […]
Key Diagnostic Findings Include: Histopathologic changes in an intestinal biopsy, characterized by crypt hyperplasia, intraepithelial lymphocytosis, and destruction of the surface epithelial lining Evidence that the small bowel enteropathy is dependent on gluten shown by positive CD-specific antibodies and/or clinical and/or histologic improvement in response to a gluten-free diet Serological Tests Can: Confirm CD in […]
OBJECTIVES: Timing of gluten introduction has been associated with the risk of celiac disease (CD) in children, but the optimal time window is unknown. We aimed to study the effect of age of gluten introduction on the risk of CD, adjusting for continued breastfeeding. METHODS: In The Norwegian Mother and Child Cohort Study, a prospective […]